Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
Abstract We have recently reported alterations in the plasma concentrations of lysophosphatidic acid (LPA) in patients with substance use disorders. In order to further explore the potential role of the LPA signaling system as biomarker in cocaine use disorders (CUD) we conducted a cross-sectional s...
Main Authors: | María Flores-López, Nuria García-Marchena, Francisco J. Pavón-Morón, Nerea Requena-Ocaña, Laura Sánchez-Marín, Laura Martín-Chaves, Mónica García-Medina, Carmen Pedraza, Estela Castilla-Ortega, Juan J. Ruiz, Fernando Rodríguez de Fonseca, Pedro Araos, Antonia Serrano |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-06-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-023-02523-1 |
Similar Items
-
Correction: Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
by: María Flores-López, et al.
Published: (2024-09-01) -
Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
by: María Flores-López, et al.
Published: (2022-04-01) -
Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex
by: Nuria García-Marchena, et al.
Published: (2022-05-01) -
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
by: Nerea Requena-Ocaña, et al.
Published: (2022-04-01) -
Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity.
by: María Pedraz, et al.
Published: (2015-01-01)